Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal Czech Filtered by asset MOH

Coverage 167,604 Raw stories ingested 22,066 rewritten in CS_CZ • 0 to rewrite (last 2 days).

Symbols 2,793 Assets with fetched stories

Cryptocurrencies BTC 7,377 ETH 4,877 XRP 3,296 SOL 3,014 HYPE 1,765 USDC 1,593

Stocks NVDA 1,800 SPCX 1,459 MU 1,335 MSFT 1,297 AAPL 1,085 TSLA 1,030

Commodities GOLD 560 SILVER 299 OIL 104 PLATINUM 14 PALLADIUM 4 COPPER 3

Forex EURUSD 505 GBPUSD 384 USDCAD 153 USDJPY 146 AUDUSD 100 USDCHF 63

2,195 with rewritten stories in CS_CZ • Hot assets ranked by fetched stories.

Agents 7 waiting Pipeline agents

FMP Stock News Fetch every minute 35s ago
FMP Forex News Fetch every 5 min 4m ago
CoinGecko News Fetch every 5 min 1m ago
FIO Stock News Fetch every 10 min 4m ago
Patria Stock News Fetch every 10 min 4m ago
Editorial rewrite Rewrite every minute 1m ago
Asset sync Assets every 1 hour 33m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

Category Source Ticker

Relevance

Clear

Details	Date	Content	Source	Relevance
	Saved 2026-08-31 10:46 10d ago Published 2026-08-27 12:26 13d ago	Molina Healthcare těží z nových smluv a zlepšuje poměr G&A Molina Healthcare těží z nových smluv v programech Medicaid a Medicare Duals a očekává zlepšení poměru G&A na 6,4 % v roce 2026 z 6,6 % v roce 2025. MOH Molina Healthcare	FMP Stock News	78
Original source text Key Takeaways Molina Healthcare benefits from Medicaid contracts, Medicare Duals growth and recent contract wins.Molina Healthcare expects its G&A ratio to improve to 6.4% in 2026 from 6.6% in 2025.MOH faces elevated medical costs, while its forward P/E exceeds both industry and five-year median levels. Molina Healthcare, Inc. (MOH - Free Report) is well-positioned for growth, supported by contract wins, strategic acquisitions and solid cash generation capacity. The company operates in three segments: Medicaid, Medicare and Marketplace. Over the past six months, MOH stock has gained 32.9% compared with the industry’s 31.8% growth. MOH – with a market cap of $10.6 billion — offers health insurance plans sponsored by the government for individuals and families. It focuses on delivering affordable and comprehensive coverage, especially for lower-income people. Courtesy of solid prospects, MOH currently carries a Zacks Rank #3 (Hold) and a Value Score of B. Where Do Estimates for MOH Stand?The Zacks Consensus Estimate for Molina Healthcare’s 2026 earnings is pegged at $5.29 per share. In the past 30 days, it has witnessed one upward estimate revision against none in the opposite direction. The consensus estimate for revenues is pegged at $44.5 billion for 2026. The 2027 revenue estimate is pegged at $48 billion, indicating a 7.9% year-over-year increase. It beat earnings estimates in two of the past four quarters and missed twice. MOH’s Growth DriversAn aging U.S. population is supporting long-term demand for government-sponsored healthcare coverage, particularly Medicare and dual-eligible plans. This creates a favorable backdrop for Molina Healthcare’s Medicare Duals business, which is becoming an increasingly important part of its portfolio. Medicare Duals delivered a second-quarter 2026 MCR of 90.7%, while the full-year MCR outlook was lowered to 92.2%. The business is also benefiting from $2 billion of MMP premium being converted into new products and incremental premium from recent contract wins. Rising healthcare needs among low-income and dual-eligible populations are creating opportunities in Medicaid and integrated care. Molina Healthcare continues to expand through state Medicaid contracts and integrated duals offerings, with the renewal of its Wisconsin contract providing additional room to grow in the latter. The company also retained its $2 billion Illinois Managed Medicaid contract, reinforcing its presence in a major Medicaid market. Beyond organic growth, MOH has an active acquisition pipeline and plans to deploy capital toward accretive deals, supporting its longer-term goal. Molina Healthcare continues to emphasize operating efficiency through its long-running restructuring and profitability initiatives. These efforts have steadily lowered its adjusted G&A ratio, which improved from 7.2% in 2023 to 6.7% in 2024 and further to 6.6% in 2025. Looking ahead, the company expects its full-year 2026 G&A ratio to improve to 6.4%. MOH's balance sheet strength provides financial flexibility. Its cash and cash equivalents of $5 billion at the end of the second quarter of 2026 were much higher than the long-term debt of $3.8 billion. Operating cash inflow was $788 million in the first six months of 2026 against an outflow of $112 million in the prior-year period. Risks for MOH StockThere are some factors, however, that investors should keep a careful eye on. Molina Healthcare continues to face pressure from elevated medical costs, with its consolidated MCR rising to 91.6% in the first half of 2026 from 89.8% a year ago. Management also expects Medicaid MCR to remain elevated through 2026, which could weigh on margin recovery. MOH trades at a premium valuation, with a forward P/E of 24.45X compared with the industry average of 16.13X and its five-year median of 14.69X. The stretched valuation may limit upside potential if earnings growth remains under pressure. Stocks to ConsiderSome better-ranked stocks in the Medical space are BrightSpring Health Services, Inc. (BTSG - Free Report) , Globus Medical, Inc. (GMED - Free Report) and Centene Corporation (CNC - Free Report) , each currently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. The Zacks Consensus Estimate for BrightSpring Health Services’ current-year earnings of $1.82 per share has witnessed six upward revisions in the past 30 days against no movement in the opposite direction. BTSG beat earnings estimates in three of the trailing four quarters and missed once, with the average surprise being 16.1%. The consensus estimate for current-year revenues is pegged at $15.3 billion, suggesting 18.2% year-over-year growth. The Zacks Consensus Estimate for Globus Medical’s current-year earnings of $4.93 per share has witnessed three upward revisions in the past 30 days, against no movement in the opposite direction. GMED beat earnings estimates in each of the trailing four quarters, with the average surprise being 27.9%. The consensus estimate for current-year revenues is pegged at $3.2 billion, suggesting 8.8% year-over-year growth. The Zacks Consensus Estimate for Centene’s current-year earnings of $4.89 per share has witnessed nine upward revisions in the past 30 days, against no movement in the opposite direction. CNC beat earnings estimates in each of the trailing four quarters, with an average surprise of 151.3%. The consensus estimate for current-year revenues is pegged at $196.3 billion, suggesting 0.8% year-over-year growth.
	Saved 2026-08-21 16:46 19d ago Published 2026-08-21 12:31 19d ago	Molina zvýšila výhled zisku navzdory poklesu tržeb Molina ve 2. čtvrtletí překonala odhad zisku na akcii, ale tržby i počet členů klesly. Firma zároveň zvýšila celoroční výhled upraveného zisku na akcii na nejméně 5,25 USD. MOH Molina Healthcare	FMP Stock News	78
Original source text A month has gone by since the last earnings report for Molina (MOH - Free Report) . Shares have lost about 1.7% in that time frame, underperforming the S&P 500. But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Molina due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. MOH Q2 Earnings Beat on Lower Operating Expenses, 2026 EPS View Raised Molina Healthcare reported second-quarter 2026 adjusted earnings per share (EPS) of $1.51, which beat the Zacks Consensus Estimate by 10.2%. The bottom line declined 72.4% from the year-ago period's level. Revenues amounted to $10.9 billion, which decreased 4.8% year over year. The top line marginally missed the consensus mark by 0.08%. Second-quarter earnings benefited from lower operating expenses. However, lower premium revenues, declining membership, and weaker investment income weighed on its performance. MOH’s Q2 Operational UpdatePremium revenues of $10.2 billion decreased 5.7% year over year and missed the Zacks Consensus Estimate by 1.8%. The decline primarily reflected lower membership levels, partially offset by pricing actions. As of June 30, 2026, total membership decreased 14.3% year over year to around 4.9 million and missed the Zacks Consensus Estimate by 1.6%. The health insurer witnessed a year-over-year decrease in customers across all segments, especially in Marketplace and Other. Investment income declined 4.7% year over year to $101 million. The figure beat the Zacks Consensus Estimate by 1.8%. Total operating expenses were $10.7 billion, down 2.9% year over year and slightly below our model estimate of $11 billion, driven by lower medical care costs. The adjusted general and administrative expense ratio increased to 6.5% from 6.1% a year ago. Interest expense increased 12.5% year over year to $54 million. The consolidated MCR (medical costs as a percentage of premium revenues) was 92.2% in the reported quarter. It rose from 90.4% a year ago but was marginally below the Zacks Consensus Estimate of 92.5%. Molina Healthcare’s adjusted net income decreased 73.8% year over year to $77 million. MOH’s Q2 Financial UpdateMolina Healthcare exited the second quarter with cash and cash equivalents of $5 billion, which increased from the 2025-end level of $4.2 billion. Total assets of $16 billion rose from $15.6 billion as of 2025-end. Long-term debt totaled $3.8 billion, which remained unchanged from the 2025-end level. Total stockholders’ equity of $4.2 billion inched up from $4.1 billion at the end of 2025. Net cash provided by operating activities was $788 million compared to net cash used in operating activities of $112 million in the prior-year period. MOH’s 2026 GuidanceThe company's full-year 2026 premium revenue guidance has remained unchanged at about $42 billion, down roughly 2% from 2025. Management expects 2026 GAAP earnings of at least $2.15 per diluted share, up from its previous guidance of at least $1.90. It also raised its full-year 2026 adjusted earnings guidance by $0.25 to at least $5.25 per diluted share. MOH raised its 2026 adjusted net income guidance to $268 million from $256 million. It also increased its GAAP net income guidance to $110 million from the previous estimate of $97 million. How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in fresh estimates. The consensus estimate has shifted -27.16% due to these changes. VGM ScoresAt this time, Molina has a average Growth Score of C, though it is lagging a bit on the Momentum Score front with a D. However, the stock has a score of B on the value side, putting it in the second quintile for value investors. Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in. OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, Molina has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
	Saved 2026-07-22 23:04 1mo ago Published 2026-07-22 18:56 1mo ago	Molina překonala odhad zisku, tržby lehce zaostaly Molina vykázala zisk na akcii 1,51 USD, nad odhadem 1,37 USD, ale tržby 10,87 miliardy USD lehce zaostaly za očekáváním. MOH Molina Healthcare	FMP Stock News	78
Original source text Molina (MOH - Free Report) came out with quarterly earnings of $1.51 per share, beating the Zacks Consensus Estimate of $1.37 per share. This compares to earnings of $5.48 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +10.22%. A quarter ago, it was expected that this provider of Medicaid-related services would post earnings of $1.57 per share when it actually produced earnings of $2.35, delivering a surprise of +49.68%. Over the last four quarters, the company has surpassed consensus EPS estimates two times. Molina, which belongs to the Zacks Medical - HMOs industry, posted revenues of $10.87 billion for the quarter ended June 2026, missing the Zacks Consensus Estimate by 0.08%. This compares to year-ago revenues of $11.43 billion. The company has topped consensus revenue estimates two times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Molina shares have added about 30.5% since the beginning of the year versus the S&P 500's gain of 9.7%. What's Next for Molina?While Molina has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Molina was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.01 on $11.06 billion in revenues for the coming quarter and $5.23 on $44.41 billion in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - HMOs is currently in the top 10% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. The Joint Corp. (JYNT - Free Report) , another stock in the same industry, has yet to report results for the quarter ended June 2026. This company is expected to post quarterly earnings of $0.11 per share in its upcoming report, which represents a year-over-year change of +283.3%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. The Joint Corp.'s revenues are expected to be $14.7 million, up 10.7% from the year-ago quarter.
	Saved 2026-07-21 15:48 1mo ago Published 2026-07-21 10:16 1mo ago	Analytici čekají prudký pokles zisku a tržeb společnosti Molina Analytici čekají, že Molina oznámí zisk 1,37 USD na akcii, což představuje meziroční pokles o 75 %, a tržby 10,88 miliardy USD, tedy o 4,8 % méně. MOH Molina Healthcare	FMP Stock News	78
Original source text Analysts on Wall Street project that Molina (MOH - Free Report) will announce quarterly earnings of $1.37 per share in its forthcoming report, representing a decline of 75% year over year. Revenues are projected to reach $10.88 billion, declining 4.8% from the same quarter last year. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe. Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock. While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight. In light of this perspective, let's dive into the average estimates of certain Molina metrics that are commonly tracked and forecasted by Wall Street analysts. The consensus among analysts is that 'Revenue- Premium revenue- Marketplace' will reach $643.41 million. The estimate indicates a change of -46.4% from the prior-year quarter. Based on the collective assessment of analysts, 'Revenue- Premium tax revenue' should arrive at $437.04 million. The estimate suggests a change of +1.4% year over year. Analysts predict that the 'Revenue- Premium revenue- Medicaid' will reach $8.16 billion. The estimate indicates a year-over-year change of +1.6%. According to the collective judgment of analysts, 'Revenue- Premium revenue- Medicare' should come in at $1.63 billion. The estimate indicates a change of +1.2% from the prior-year quarter. The average prediction of analysts places 'MCR - Medicaid' at 92.9%. Compared to the present estimate, the company reported 91.3% in the same quarter last year. The collective assessment of analysts points to an estimated 'MCR - Medicare' of 93.7%. Compared to the present estimate, the company reported 90.0% in the same quarter last year. Analysts expect 'MCR - Marketplace' to come in at 84.9%. Compared to the current estimate, the company reported 85.4% in the same quarter of the previous year. The consensus estimate for 'Ending Membership by Program - Total' stands at 5.00 million. The estimate is in contrast to the year-ago figure of 5.75 million. It is projected by analysts that the 'Ending Membership by Program - Medicaid' will reach 4.48 million. Compared to the current estimate, the company reported 4.77 million in the same quarter of the previous year. Analysts' assessment points toward 'Ending Membership by Program - Medicare' reaching 230.66 thousand. The estimate compares to the year-ago value of 267.00 thousand. Analysts forecast 'Ending Membership by Program - Marketplaces' to reach 285.05 thousand. The estimate is in contrast to the year-ago figure of 690.00 thousand. The combined assessment of analysts suggests that 'MCR - Total' will likely reach 92.5%. Compared to the present estimate, the company reported 90.4% in the same quarter last year. View all Key Company Metrics for Molina here>>> Molina shares have witnessed a change of +16.4% in the past month, in contrast to the Zacks S&P 500 composite's -0.6% move. With a Zacks Rank #3 (Hold), MOH is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .